Pulmonary Arterial Hypertension (Pah) Drugs Market 2024-2028
Incremental Growth2024-2028 (US$mn)
$ 2264.7
2024 Year-over-Year Growth
6.23%
CAGR (2024-2028)
6.78%
Report Coverage
Global
Pulmonary Arterial Hypertension (Pah) Drugs Market Segmentation
Market Segmentation & Scope
Market Segment by Geographic Landscape
47%
of the growth will originate
from North America
Global Market Size 2018 - 2028 (US$ Mn)
Market is segmented by Route Of Administration into Oral, Injectable, Inhalation
The Oral is expected to be largest growing segment during 2024-2028
Largest Segment - Oral
US$ 16,514.40 Mn
Pulmonary Arterial Hypertension (Pah) Drugs Market by Route Of Administration into Oral; 2018-2028 (US$ Mn)
Oral Market Revenue and Forecast 2018-2028 (US$ Mn)Oral
- Oral Market Size and Forecast 2018 to 2028 (US$ Mn)
Pulmonary Arterial Hypertension (Pah) Drugs Market by Route Of Administration into Injectable; 2018-2028 (US$ Mn)
Injectable Market Revenue and Forecast 2018-2028 (US$ Mn)Injectable
- Injectable Market Size and Forecast 2018 to 2028 (US$ Mn)
Pulmonary Arterial Hypertension (Pah) Drugs Market by Route Of Administration into Inhalation; 2018-2028 (US$ Mn)
Inhalation Market Revenue and Forecast 2018-2028 (US$ Mn)Inhalation
- Inhalation Market Size and Forecast 2018 to 2028 (US$ Mn)
Market is segmented by Action Mechanism into Prostacyclin analogs, Endothelin receptor antagonists (ERAs), Phosphodiesterase (PDE) inhibitors, Soluble guanylate cyclase stimulators (SGCSs)
The Prostacyclin analogs is expected to be largest growing segment during 2024-2028
Largest Segment - Prostacyclin analogs
US$ 12,159.00 Mn
Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Segmentation, by Action Mechanism (US$ Mn)
| Action Mechanism | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prostacyclin analogs | 2210.40 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Endothelin receptor antagonists (ERAs) | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Phosphodiesterase (PDE) inhibitors | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Soluble guanylate cyclase stimulators (SGCSs) | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Pulmonary Arterial Hypertension (Pah) Drugs Market by Action Mechanism into Prostacyclin analogs; 2018-2028 (US$ Mn)
Prostacyclin analogs Market Revenue and Forecast 2018-2028 (US$ Mn)Prostacyclin analogs
- Prostacyclin analogs Market Size and Forecast 2018 to 2028 (US$ Mn)
Pulmonary Arterial Hypertension (Pah) Drugs Market by Action Mechanism into Endothelin receptor antagonists (ERAs); 2018-2028 (US$ Mn)
Endothelin receptor antagonists (ERAs) Market Revenue and Forecast 2018-2028 (US$ Mn)Endothelin receptor antagonists (ERAs)
- Endothelin receptor antagonists (ERAs) Market Size and Forecast 2018 to 2028 (US$ Mn)
Pulmonary Arterial Hypertension (Pah) Drugs Market by Action Mechanism into Phosphodiesterase (PDE) inhibitors; 2018-2028 (US$ Mn)
Phosphodiesterase (PDE) inhibitors Market Revenue and Forecast 2018-2028 (US$ Mn)Phosphodiesterase (PDE) inhibitors
- Phosphodiesterase (PDE) inhibitors Market Size and Forecast 2018 to 2028 (US$ Mn)
Pulmonary Arterial Hypertension (Pah) Drugs Market by Action Mechanism into Soluble guanylate cyclase stimulators (SGCSs); 2018-2028 (US$ Mn)
Soluble guanylate cyclase stimulators (SGCSs) Market Revenue and Forecast 2018-2028 (US$ Mn)Soluble guanylate cyclase stimulators (SGCSs)
- Soluble guanylate cyclase stimulators (SGCSs) Market Size and Forecast 2018 to 2028 (US$ Mn)
Market is segmented by Geography into North America, Europe, Asia, ROW
The North America is estimated to contribute 47% to the growth of global market during the forecast period 2024-2028.
Largest Segment - North America
47%
Regional share of different regions, including North America, Europe, Asia, Rest of World (ROW)
| Region | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2232.40 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Europe | XX | 1514.50 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Asia | XX | XX | 644.00 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| ROW | XX | XX | XX | 358.70 | 373.80 | XX | XX | XX | XX | XX | XX | XX |
Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Geography into North America; 2018-2028 (US$ Mn)
North America Market Revenue and Forecast 2018-2028 (US$ Mn)Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Country into Canada; 2018-2028 (US$ Mn)
Canada Market Revenue and Forecast 2018-2028 (US$ Mn)Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Country into US; 2018-2028 (US$ Mn)
US Market Revenue and Forecast 2018-2028 (US$ Mn)Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Geography into Europe; 2018-2028 (US$ Mn)
Europe Market Revenue and Forecast 2018-2028 (US$ Mn)Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Country into Germany; 2018-2028 (US$ Mn)
Germany Market Revenue and Forecast 2018-2028 (US$ Mn)Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Country into UK; 2018-2028 (US$ Mn)
UK Market Revenue and Forecast 2018-2028 (US$ Mn)Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Geography into Asia; 2018-2028 (US$ Mn)
Asia Market Revenue and Forecast 2018-2028 (US$ Mn)Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Country into Japan; 2018-2028 (US$ Mn)
Japan Market Revenue and Forecast 2018-2028 (US$ Mn)Pulmonary Arterial Hypertension (Pah) Drugs Market Size by Geography into ROW; 2018-2028 (US$ Mn)
ROW Market Revenue and Forecast 2018-2028 (US$ Mn)Major Companies
Market Companies
| Name | Profile | Employees | Headquarters | Website | |
|---|---|---|---|---|---|
| Aerami Therapeutics Holdings Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Aerovate Therapeutics Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Alembic Pharmaceuticals Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Asklepion Pharmaceuticals LLC | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bayer AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Daiichi Sankyo Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Dr Reddys Laboratories Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Eiger BioPharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Gilead Sciences Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| GlaxoSmithKline Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Johnson and Johnson Services Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Lupin Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Merck and Co. Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Reata Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Teva Pharmaceutical Industries Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| United Therapeutics Corp. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Viatris Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Pulmonary Arterial Hypertension (Pah) Drugs Market Scope
- By Route Of Administration
- Introduction / Key Findings
- Historical Market Size Value (US$ million) Analysis By Route Of Administration, 2017 to 2022
- Current and Future Market Size Value (US$ million) Analysis and Forecast By Route Of Administration, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Route Of Administration, 2017 to 2022
- Absolute $ Opportunity Analysis By Route Of Administration, 2024 to 2028
- By Action Mechanism
- Introduction / Key Findings
- Historical Market Size Value (US$ million) Analysis By Action Mechanism, 2017 to 2022
- Current and Future Market Size Value (US$ million) Analysis and Forecast By Action Mechanism, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Action Mechanism, 2017 to 2022
- Absolute $ Opportunity Analysis By Action Mechanism, 2024 to 2028
- By Region
- Introduction / Key Findings
- Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022
- Current and Future Market Size Value (US$ million) Analysis and Forecast By Region, 2024 to 2028
- North America Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ million) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ million) Forecast By Market, 2024 to 2028
- By Country
- By Route Of Administration
- By Action Mechanism
- Europe Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ million) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ million) Forecast By Market, 2024 to 2028
- By Country
- By Route Of Administration
- By Action Mechanism
- Asia Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ million) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ million) Forecast By Market, 2024 to 2028
- By Country
- By Route Of Administration
- By Action Mechanism
- Rest of World (ROW) Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ million) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ million) Forecast By Market, 2024 to 2028
- By Route Of Administration
- By Action Mechanism
Major Companies
Market companies
| Name | Profile | Employees | Headquarters | Website | |
|---|---|---|---|---|---|
| Aerami Therapeutics Holdings Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Aerovate Therapeutics Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Alembic Pharmaceuticals Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Asklepion Pharmaceuticals LLC | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bayer AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Daiichi Sankyo Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Dr Reddys Laboratories Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Eiger BioPharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Gilead Sciences Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| GlaxoSmithKline Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Johnson and Johnson Services Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Lupin Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Merck and Co. Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Reata Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Teva Pharmaceutical Industries Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| United Therapeutics Corp. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Viatris Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Subscribe to World-Class Market Intelligence
Basic Plan
Experience the best of reports & insights
